sec filing
DM
NASDAQ · DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
Financial Services · Shell Companies
$10.19
Up+$0.00 (+0.00%)
Updated Oct 10, 2026, 6:49 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 518.58M
- P/E ratio
- -54.87
- Dividend yield
- 0.00%
- 52-week range
- $9.94 – $10.33
- Volume
- 600.24K
- Avg. volume
- 429.72K
Price performance · DMII
DMII price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
DMII closed at $10.19 after 20 trading sessions, up 0.27% for the selected period.
- Last close
- $10.19
- Period change
- +0.27%
- Period low
- $10.15
- Period high
- $10.19
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $10.19 | $10.19 | $10.19 | $10.19 | 600.24K |
| Oct 8, 2026 | $10.19 | $10.19 | $10.19 | $10.19 | 250.24K |
| Oct 7, 2026 | $10.20 | $10.20 | $10.18 | $10.19 | 119.05K |
| Oct 6, 2026 | $10.20 | $10.20 | $10.18 | $10.185 | 103.33K |
| Oct 5, 2026 | $10.19 | $10.19 | $10.18 | $10.19 | 2.24K |
| Oct 2, 2026 | $10.19 | $10.195 | $10.19 | $10.19 | 17.65K |
| Oct 1, 2026 | $10.18 | $10.195 | $10.18 | $10.19 | 132.51K |
| Sep 30, 2026 | $10.18 | $10.18 | $10.18 | $10.18 | 1.22K |
| Sep 29, 2026 | $10.17 | $10.175 | $10.17 | $10.175 | 16.87K |
| Sep 25, 2026 | $10.155 | $10.16 | $10.155 | $10.16 | 26.43K |
| Sep 24, 2026 | $10.1528 | $10.1528 | $10.15 | $10.15 | 228.8 |
| Sep 23, 2026 | $10.16 | $10.16 | $10.16 | $10.16 | 2.17K |
| Sep 22, 2026 | $10.155 | $10.155 | $10.155 | $10.155 | 220 |
| Sep 21, 2026 | $10.33 | $10.33 | $10.155 | $10.155 | 37.87K |
| Sep 18, 2026 | $10.18 | $10.18 | $10.17 | $10.17 | 153.56K |
| Sep 17, 2026 | $10.18 | $10.18 | $10.165 | $10.175 | 381.37K |
| Sep 16, 2026 | $10.165 | $10.17 | $10.16 | $10.16 | 30.05K |
| Sep 15, 2026 | $10.16 | $10.18 | $10.16 | $10.17 | 215.13K |
| Sep 14, 2026 | $10.17 | $10.18 | $10.17 | $10.18 | 3.42K |
| Sep 11, 2026 | $10.1758 | $10.1758 | $10.1628 | $10.1628 | 1.6K |
Latest DMII news
The latest Smart Investors Daily articles mentioning DMII.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DMII research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition II Corp is a blank check Company.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.